Caesarean Hysterectomy Versus Conservative Management of Placenta Accreta: A Comparative Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorCairo University

About this trial

Placenta accreta rates are rising alongside the rising rates of caesarean deliveries. This has lead to a vast number of studies negotiating the histopathological nature, risk factors and outcomes of pregnancies complicated with placenta accreta. In the study the investigators re discussing the outcome of different plans of management of placenta accreta, namely caesarean hysterectomy and focal myometrium resection.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Singleton pregnancy with living fetus

Average liquor: 5-25 cm

Gestational age ≥ 34 weeks at time of termination

Previous lower segment cesarean section/s

Disqualifiers

Hepatic, cardio-pulmonary or coagulation disorders

Hemoglobin< 9.5g/dl

Ruptured membranes

Need for emergency delivery as Antepartum hemorrhage or contractions

Trial population

A total number of 36 pregnant patients at or after 34 weeks diagnosed of having placenta accreta spectrum were admitted and managed in Kasr Al-Ainy School of Medicine Hospital.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Caesarean Hysterectomy

    Procedure/Surgery

    Caesarean delivery followed by hysterectomy

  • Conservative management

    Procedure/Surgery

    Focal myometrium resection of the area of diseased myometrium after delivery

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: 1 (Caesarean Hysterectomy group)1 intervention
Group B: 2 ( Conservative Management group)1 intervention

Trial outcomes

Primary outcomes

1

operative blood loss

hemoglobin deficit in mg/dl

Time frame
6 months

Secondary outcomes

1

operative blood loss

visual estimation of operative blood loss in ml

Time frame
6months
2

need for blood products transfusion

no of blood products transfused in both groups in no. of units

Time frame
6months
3

adjacent organ injuries

rates of urinary bladder or ureteric injuries

Time frame
6months
4

operative time

operative time in minutes

Time frame
6months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: